Merck HPV vaccine for men approved in China Ruchika Sharma8 Jan 2025 4:43 PM ISTMerck & Co's human papillomavirus (HPV) vaccine, Gardasil, has received approval from China's medical products administration for men aged...
Merck to acquire WuXi Biologics Ireland vaccine facility for USD 500 million Ruchika Sharma8 Jan 2025 10:00 AM ISTChina's WuXi Biologics has announced plans to sell its vaccine facility in Ireland to U.S. pharmaceutical giant Merck & Co. for approximately...
Merck gets UK approval for lung disease drug Sotatercept Ruchika Sharma1 Jan 2025 3:13 PM ISTMerck has received approval from the UK's Medicines and Healthcare products Regulatory Agency for its therapy, sotatercept, to treat a rare lung...
Merck to discontinue bacterial infection drug Zinplava Ruchika Sharma26 Dec 2024 5:44 PM ISTMerck will discontinue its antibody-drug Zinplava for a bacterial infection that can lead to fatal diarrhea, according to the U.S. Food and...
Merck closes exclusive global license agreement for LM-299 Ruchika Sharma23 Dec 2024 4:01 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced the closing of the exclusive global license agreement for LM-299, a...
Merck, Hansoh Pharma ink pact for oral small molecule GLP-1 receptor agonist Ruchika Sharma20 Dec 2024 11:30 AM ISTRahway: Merck, known as MSD outside of the United States and Canada, and Hansoh Pharma, a Chinese biopharmaceutical company, have announced that...
Merck application for RSV treatment Clesrovimab for infants accepted by USFDA Ruchika Sharma19 Dec 2024 11:30 AM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced the U.S. Food and Drug Administration (FDA) has accepted...
Merck discontinues clinical development programs for vibostolimab, favezelimab Ruchika Sharma18 Dec 2024 3:30 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced the discontinuation of the clinical development programs for...
Phase 3 KEYLYNK-001 Trial Met Primary Endpoint of Progression-Free Survival in Patients With Advanced Epithelial Ovarian Cancer: Merck Ruchika Sharma11 Dec 2024 5:54 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced that the Phase 3 KEYLYNK-001 trial evaluating KEYTRUDA...
USFDA grants Breakthrough Therapy Designation to Sacituzumab Tirumotecan for Metastatic Nonsquamous Non Small Cell Lung Cancer with EGFR Mutations: Merck Ruchika Sharma4 Dec 2024 1:01 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced that the U.S. Food and Drug Administration (FDA) has granted...
Merck gets positive EU CHMP opinion for Keytruda plus Chemotherapy as first-line treatment for adult patients with unresectable non-eithelioid Malignant Pleural Mesothelioma Ruchika Sharma19 Nov 2024 2:30 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced that the European Medicines Agency's Committee for Medicinal...
Ginkgo Bioworks advances collaboration with Merck to improve Biologics manufacturing Ruchika Sharma14 Nov 2024 12:33 PM ISTBoston: Ginkgo Bioworks has announced the completion of the first milestone of a previously announced partnership with Merck, known as MSD outside of...
